646 results on '"Kosiorek, Heidi E."'
Search Results
52. Same-day Discharge Is Safe and Effective After Implant-Based Breast Reconstruction
53. A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
54. Diabetes mellitus and blood glucose variability increases the 30‐day readmission rate after kidney transplantation.
55. Does Prior Breast Augmentation Affect Outcomes After Mastectomy With Reconstruction? An Analysis of Postoperative Complications and Reoperations
56. Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection
57. Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study
58. Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion
59. Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
60. Co-Existing Prostate Cancer and Diabetes Mellitus: Implications for Patient Outcomes and Care
61. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
62. Decline in the seroprevalence of syphilis markers among first-time blood donors in Libreville (Gabon) between 2004 and 2016
63. Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone
64. Mediterranean Diet Intervention in Patients with Myeloproliferative Neoplasm
65. Molecularly Targeted Combination Therapy for Advanced Phase Myeloproliferative Neoplasm: MPN-RC 119
66. Evaluating the Impact of Breast and Nipple Sensation on Quality-of-Life after Nipple-sparing Mastectomy with Implant Reconstruction: Long-term Outcomes Utilizing Breast-Q
67. Cancer, diabetes, survival and glycemic control: a large multisite analysis
68. IAP antagonists induce anti-tumor immunity in multiple myeloma
69. Type 1 interferon remodels normal and neoplastic hematopoiesis in human
70. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy
71. Seldom one and done: Characterizing rates of reoperation with direct-to-implant breast reconstruction after mastectomy
72. Pancreatitis in Patients With Pancreas Divisum
73. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
74. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast
75. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma
76. Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study
77. The impact of genetic aberrations on response to radium‐223 treatment for castration‐resistant prostate cancer with bone metastases
78. Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.
79. P149. EVALUATING THE IMPACT OF BREAST AND NIPPLE SENSATION ON QUALITY-OF-LIFE AFTER NIPPLE-SPARING MASTECTOMY WITH IMPLANT RECONSTRUCTION: LONG-TERM OUTCOMES UTILIZING BREAST-Q
80. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study
81. Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers
82. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations
83. Treatment of Myelofibrosis Patients with the TGF-β 1/3 Inhibitor AVID200 (MPN-RC 118) Induces a Profound Effect on Platelet Production
84. Single-Cell Multi-Omics Reveals That Pegylated Interferon-Alfa Treatment Differentially Redirects Mutated and Wildtype Hematopoietic Cell Differentiation Trajectories in CALR-mutated Essential Thrombocythemia (ET) Patients
85. An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
86. Identifying opportunities to improve equity in breast cancer care for uninsured Hispanic patients in underserved communities.
87. Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score
88. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms
89. Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence‐free survival
90. Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
91. Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population
92. Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case–control study
93. Comparison of care process for newly diagnosed breast cancer in insured versus uninsured populations: Opportunities for improving health equity.
94. Impact of advanced clinical and translational research educational programs on oncology specialties and career development.
95. Circulating cell free tumor DNA detection as a prognostic tool in advanced pancreatic cancer.
96. Capsular contracture in the modern era: A multidisciplinary look at the incidence and risk factors after mastectomy and implant-based breast reconstruction
97. Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series
98. Advancing Effective Clinical Trial Designs for Myelofibrosis
99. Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
100. Symptom Burden and Quality of Life in High-Risk Essential Thrombocythemia and Polycythemia Vera Patients Receiving Hydroxyurea or Pegylated Interferon Alfa-2a: Results of Myeloproliferative Neoplasms Research Consortium (MPN-RC) 111 and 112 Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.